Cost-effectiveness analysis of colorectal cancer treatments.
A concise overview is provided of the methodology of cost-effectiveness analyses, followed by a survey of published CEAs of colorectal cancer treatments. To gain credibility, the methodology applied in CEAs must be further improved. Costs are rarely estimated from the societal perspective, and little is known about how colorectal patients value their treatment and health.
van den Hout
W B
WB
Department of Medical Decision Making, Leiden University Medical Center, PO Box 9600, 2300 RC, Leiden, The Netherlands. w.b.van_den_hout@lumc.edu
van den Brink
M
M
Stiggelbout
A M
AM
van de Velde
C J H
CJ
Kievit
J
J
D017024:Chemotherapy, Adjuvant / Q000191:economics; D015179:Colorectal Neoplasms / Q000191:economics* / Q000628:therapy; D003362:Cost-Benefit Analysis; D005500:Follow-Up Studies; D017048:Health Care Costs; D006801:Humans; D019057:Quality-Adjusted Life Years